MedPath

吉林一正药业集团有限公司

Ownership
-
Established
2003-04-23
Employees
-
Market Cap
-
Website
http://www.yizheng.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

132

NMPA:132

Drug Approvals

复方丹参片

Approval Number
国药准字Z22022524
Approval Date
Feb 21, 2025
NMPA

Hydrotalcite Chewable Tablets

Product Name
铝碳酸镁咀嚼片
Approval Number
国药准字H20173403
Approval Date
Feb 1, 2023
NMPA

Metronidazole Suppositories

Product Name
甲硝唑栓
Approval Number
国药准字H20173368
Approval Date
Nov 15, 2022
NMPA

一正<sup>®</sup> 黄芪党参阿胶口服液

Approval Number
国食健注G20050580
Approval Date
Aug 16, 2021
NMPA

一正<sup>®</sup> 佰瑞胶囊

Approval Number
国食健注G20141240
Approval Date
Jul 26, 2021
NMPA

一正<sup>&reg</sup>玛咖人参红景天片

Approval Number
国食健注G20210090
Approval Date
Jul 5, 2021
NMPA

一正<sup>®</sup> 左旋肉碱荷叶胶囊

Approval Number
国食健注G20060755
Approval Date
Feb 5, 2021
NMPA

一正<sup>®</sup> 捷力胶囊

Approval Number
国食健注G20160010
Approval Date
Jan 26, 2021
NMPA

一正<sup>®</sup>大豆异黄酮珍珠粉胶囊

Approval Number
国食健注G20110363
Approval Date
Oct 28, 2020
NMPA

理中丸

Approval Number
国药准字Z20153018
Approval Date
Sep 10, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 14
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.